Letter to the Editor: 100-day window: Reframing early follow-up and parental guidance in recurrent wheezing

In paediatric treatment, persistent wheeze in babies continues to pose significant challenges for identification and management. The forthcoming retrospective cohort study recently published in World Journal of Clinical Pediatrics, entitled "Understanding recurrent wheezing: A parent's Guide" by Kiatvitchukul et al offers essential insights by pinpointing independent factors linked to recurrence, such as age 12-24 months, preterm birth, allergic rhinitis, eosinophilia, and previous lower respiratory tract infections. The median time to recurrence of about 100 days is important since it shows that there is a good potential for quick treatment and comprehensive follow-up. This comment makes it clear how crucial it is to use this kind of proof in both community and clinical settings. By checking for clinical signs and chatting to their parents, you can find kids who are at high risk early on. This makes it easier to give them customized counselling, reduce their exposure to allergens, and start them on controller medicines when they need them. The study's results show that pediatricians, allergists, and carers need to work together to stop the same problems from happening again and cut down on hospital readmissions. By changing how they see the "100-day window" as an important time for monitoring and putting preventive measures into action, pediatricians can improve outcomes and give families more control over their child's respiratory health. We need more multicenter prospective research to learn more about the biological, environmental, and socioeconomic factors that lead to recurrence. This will help us turn these findings into standard approaches to care for people.